Correlation Between Siemens Healthineers and Bone Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Siemens Healthineers and Bone Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Siemens Healthineers and Bone Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Siemens Healthineers AG and Bone Biologics Corp, you can compare the effects of market volatilities on Siemens Healthineers and Bone Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Siemens Healthineers with a short position of Bone Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Siemens Healthineers and Bone Biologics.

Diversification Opportunities for Siemens Healthineers and Bone Biologics

0.46
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Siemens and Bone is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Siemens Healthineers AG and Bone Biologics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bone Biologics Corp and Siemens Healthineers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Siemens Healthineers AG are associated (or correlated) with Bone Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bone Biologics Corp has no effect on the direction of Siemens Healthineers i.e., Siemens Healthineers and Bone Biologics go up and down completely randomly.

Pair Corralation between Siemens Healthineers and Bone Biologics

Assuming the 90 days horizon Siemens Healthineers AG is expected to generate 0.32 times more return on investment than Bone Biologics. However, Siemens Healthineers AG is 3.1 times less risky than Bone Biologics. It trades about 0.1 of its potential returns per unit of risk. Bone Biologics Corp is currently generating about -0.07 per unit of risk. If you would invest  2,600  in Siemens Healthineers AG on September 1, 2024 and sell it today you would earn a total of  96.00  from holding Siemens Healthineers AG or generate 3.69% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.45%
ValuesDaily Returns

Siemens Healthineers AG  vs.  Bone Biologics Corp

 Performance 
       Timeline  
Siemens Healthineers 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Siemens Healthineers AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Siemens Healthineers is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Bone Biologics Corp 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Bone Biologics Corp are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak essential indicators, Bone Biologics reported solid returns over the last few months and may actually be approaching a breakup point.

Siemens Healthineers and Bone Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Siemens Healthineers and Bone Biologics

The main advantage of trading using opposite Siemens Healthineers and Bone Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Siemens Healthineers position performs unexpectedly, Bone Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bone Biologics will offset losses from the drop in Bone Biologics' long position.
The idea behind Siemens Healthineers AG and Bone Biologics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope